Evaluating the prognostic value of time to metastasis in metachronous mHSPC

(5:54)

What is the prognostic classification of MDS?

(2:15)

The prognostic value of MRD in CLL

(1:19)

The prognostic value of post-therapy LuPSMA-SPECT/CT in mCRPC

(2:39)

The prognostic value of MRD negativity

(3:14)

The prognostic value of peripheral blood MRD status following Elo-KRd in newly diagnosed myeloma

(4:26)

Evaluating the prognostic value of CTCs in patients with myeloma enrolled in the PERSEUS trial

(3:19)

The prognostic value of self-reported fatigue on overall survival in patients with MDS

(1:6)

ctDNA may have a prognostic role in stage III colon cancer treated with celecoxib

(5:45)

Pronostic PMU Quinté Flash à Vincennes, R1C8 du 28 février 2025

(3:51)

AT THE CROSSROADS | The CrossFit uncertainty and WFP

(12:1econd)

GuruSangam 2025 - Episode 17 NEURO-OPHTHALMOLOGY

(2:18:6)

TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles

(23:4)

What is HRMM (High-Risk Multiple Myeloma)? #myeloma

(5:59)

Current status \u0026 updates in the management of AL amyloidosis

(5:14)

Organ Involvement in AL amyloidosis

(4:33)

February 26, 2025 VMR with Sharmin \u0026 Reza - headache

(58:34)

What pathologies of the aorta can be visualized in TEE?

(1:20)

AL amyloidosis and a critical, early diagnosis

(6:47)

Defining ALL risk factors: the prognostic index

(2:32)

The prognostic value of structural heterogeneity of chromosome 1q in multiple myeloma

(1:53)

The prognostic value of patient-reported outcomes in MDS

(1:30)

Assessing the prognostic value of NGS-based MRD in adults with ALL undergoing SCT

(2:41)

Dr. Deek on the Prognostic Significance of Immune Cell Infiltration in MIBC

(4:31)

The prognostic impact of TP53 mutation in MPNs

(46)

What is the prognostic value of STE?

(2:9)

The prognostic impact of TP53 and IgHV status in the era of targeted therapies in CLL

(2:2)

The Prognostic Value of Molecular Testing

(2:53)

Evaluating the prognostic value of PSMA PET/CT in mCRPC

(10:1econd)

Investigating the prognostic impact of immunoarchitectural patterns in NLPHL

(1:30)